Search
for
Sort by
Research 151–180 of 1000+
- Adverse cutaneous effects of psychotropic medications
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Cutaneous lupus erythematosus
- Cutaneous Manifestations of Eating Disorders
- Cutaneous manifestations of systemic lupus erythematosus
- The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future
- High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole
- Formulation And Evaluation Of Emulgel Of An Antifungal Drug For Topical Drug Delivery
- Changing incidence trends of cutaneous B-cell lymphoma
- Drug repositioning using <i>in silico</i> compound profiling
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- An Update on Drug-Induced Pigmentation
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Nanocarrier Systems for Transdermal Drug Delivery
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Cutaneous Lupus Erythematosus
- Cutaneous manifestations of systemic infection in children
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- An overview of management of drug-induced hair and nail disorders
- Vaping Culture and Cutaneous Health: A Trend with Skin-Deep Consequences
- Cutaneous signals of immune system disease
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- Cutaneous Lupus Erythematosus Presenting as Frontal Fibrosing Alopecia: Report of 2 Patients